(Q69253729)
Statements
Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patients (English)
T S Elizan
M D Yahr
D A Moros
M R Mendoza
S Pang
1 December 1989